Royal Bank Of Canada Ice Cure Medical Ltd. Transaction History
Royal Bank Of Canada
- $579 Billion
- Q3 2025
A detailed history of Royal Bank Of Canada transactions in Ice Cure Medical Ltd. stock. As of the latest transaction made, Royal Bank Of Canada holds 500 shares of ICCM stock, worth $355. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500
Previous 500
-0.0%
Holding current value
$355
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ICCM
# of Institutions
18Shares Held
294KCall Options Held
0Put Options Held
0-
Two Sigma Securities, LLC New York, NY50.2KShares$35,6220.01% of portfolio
-
Hrt Financial LP New York, NY46.7KShares$33,1550.0% of portfolio
-
Geode Capital Management, LLC Boston, MA40.5KShares$28,7210.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il37.2KShares$26,3920.0% of portfolio
-
Lpl Financial LLC Fort Mill, SC23.4KShares$16,5960.0% of portfolio
About IceCure Medical Ltd.
- Ticker ICCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 36,835,600
- Market Cap $26.2M
- Description
- IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.